🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Krishna Institute of Medical Sciences Limited KIMS NIFTY_SMALLNSEPHARMA

Healthcare · Medical Care Facilities · India
https://www.kimshospitals.com

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics. In addition, the company offers orthopedics, arthroscopic and spine surgery, and ortho rehabilitation; medical surgical and radiation, and BMT and hematology; ophthalmology; dermatology, cosmetology, and plastic and reconstructive surgery; and clinical infectious diseases. Further, it provides imaging and interventional radiology; paediatrics and pediatric sub specialities, and neonatology; maxillo-facial surgery; OT and day care anaesthesia and pain medicine; and pathology, microbiology, and biochemistry. Additionally, the company offers molecular biology and clinical hematology; internal medicine, general surgery, and diabetology and endocrinology; and ICU, CTICU, SICU, NICU, PICU, neuro and ECMO ICU, and post transplant ICU services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

READ MORE ›
₹758.85
+16.90% 1Y

Market & Price

Market Cap
₹30,364.54 Cr
Current Price
₹758.85
High / Low (52W)
₹789.35 / ₹582.10
Beta
0.13

Valuation

Stock P/E
126.69
Industry PE
37.60
Forward P/E
43.82
PEG Ratio
-
Book Value
₹56.05
Price to Book
13.54
P/S
7.78
EV/EBITDA
43.52
Dividend Yield
-

Profitability & Returns

ROCE
8.23%
ROE
9.72%
ROA
4.81%
Profit Margin
6.18%
Op Margin
11.31%
EPS (Latest Qtr)
₹1.06
EPS (TTM)
₹5.99

Balance Sheet & Liquidity

Debt/Equity
1.66
Quick Ratio
0.52
Current Ratio
0.76
Debt
₹4,252.90 Cr
Total Assets
₹7,758.70 Cr
Current Assets
₹937.40 Cr
Working Capital
₹-301.50 Cr

Ownership

Promoter Holding
43.80%
Chg in Prom Hold
-
FII / Inst Holding
39.79%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹34,899.79 Cr
Total Revenue (TTM)
₹3,904.60 Cr
EBITDA
₹802.00 Cr
Free Cash Flow
₹-1,142.31 Cr
Operating Cash Flow
₹510.80 Cr
Shares Outstanding
₹40.01 Cr
Gross Margin
61.82%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
21.67%
Profit 5Y
-10.46%
Revenue (YoY)
34.80%
Earnings (YoY)
-58.30%

PROS

  • Compounding revenue at 21.7% over 5 years.

CONS

  • Trading at a high P/E of 126.7.
  • Earnings shrank at -10.5% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 KIMS Krishna Institute of Medical Sciences Limited NIFTY_SMALLNSEPHARMA 758.85 126.69 ₹30,364.54 Cr - 8.23% 9.72% 21.67% -10.46%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
Ad space

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 796.90 Cr871.60 Cr960.70 Cr997.70 Cr1,074.60 Cr
Cost of Revenue 301.20 Cr335.00 Cr195.20 Cr196.90 Cr412.70 Cr
Gross Profit 495.70 Cr536.60 Cr765.50 Cr800.80 Cr661.90 Cr
Operating Expenses 350.30 Cr397.40 Cr627.60 Cr680.60 Cr540.40 Cr
Operating Income 145.40 Cr139.20 Cr137.90 Cr120.20 Cr121.50 Cr
EBITDA 213.30 Cr199.70 Cr207.90 Cr204.10 Cr207.90 Cr
Interest Expense 26.70 Cr32.60 Cr45.00 Cr56.80 Cr68.10 Cr
Pretax Income 134.00 Cr113.70 Cr96.80 Cr68.60 Cr54.80 Cr
Tax Provision 27.90 Cr28.70 Cr24.80 Cr16.70 Cr21.70 Cr
Net Income 101.80 Cr78.60 Cr66.90 Cr53.40 Cr42.50 Cr
Diluted EPS 2.541.961.671.331.06

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -2,167.66 Cr2,474.00 Cr3,035.00 Cr3,904.60 Cr
Cost of Revenue -827.08 Cr952.80 Cr1,126.40 Cr1,490.60 Cr
Gross Profit -1,340.58 Cr1,521.20 Cr1,908.60 Cr2,414.00 Cr
Operating Expenses -851.11 Cr1,018.70 Cr1,303.00 Cr1,895.20 Cr
Operating Income -489.47 Cr502.50 Cr605.60 Cr518.80 Cr
EBITDA -643.49 Cr652.40 Cr825.60 Cr819.60 Cr
Interest Expense -29.32 Cr46.40 Cr90.30 Cr202.50 Cr
Pretax Income -484.91 Cr459.50 Cr558.10 Cr333.90 Cr
Tax Provision -119.09 Cr123.60 Cr143.30 Cr91.90 Cr
Net Income -336.32 Cr310.00 Cr384.50 Cr241.40 Cr
Diluted EPS 8.388.417.759.61-

Compounded Sales Growth

5 Years:21.67%
1 Year:34.80%

Compounded Profit Growth

5 Years:-10.46%
1 Year:-58.30%

Stock Price Performance

1 Year:+16.90%
6 Months:+11.85%
3 Months:+5.77%
1 Month:+14.07%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -2,941.30 Cr3,851.70 Cr5,736.00 Cr7,758.70 Cr
Current Assets -477.64 Cr547.30 Cr697.30 Cr937.40 Cr
Cash & Equivalents -61.61 Cr46.90 Cr56.00 Cr55.40 Cr
Inventory -42.87 Cr49.40 Cr64.00 Cr96.90 Cr
Receivables -252.65 Cr294.40 Cr395.40 Cr554.20 Cr
Total Liabilities -1,003.34 Cr1,758.60 Cr3,317.20 Cr5,200.20 Cr
Current Liabilities -296.47 Cr451.90 Cr836.20 Cr1,238.90 Cr
Long Term Debt -497.44 Cr927.70 Cr1,654.10 Cr2,672.60 Cr
Total Debt -678.17 Cr1,355.50 Cr2,556.70 Cr4,252.90 Cr
Total Equity -1,669.54 Cr1,828.20 Cr2,137.80 Cr2,247.40 Cr
Shares Outstanding -40.01 Cr40.01 Cr40.01 Cr40.01 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -432.09 Cr521.20 Cr581.80 Cr510.80 Cr
Investing Cash Flow --546.89 Cr-752.60 Cr-1,116.20 Cr-1,451.70 Cr
Financing Cash Flow -19.64 Cr216.70 Cr543.10 Cr940.30 Cr
Capital Expenditure --574.52 Cr-647.30 Cr-1,008.90 Cr-1,427.90 Cr
Free Cash Flow --142.44 Cr-126.10 Cr-427.10 Cr-917.10 Cr
Net Change in Cash --95.17 Cr-14.70 Cr8.70 Cr-60.00 L

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -61.8%61.5%62.9%61.8%
Operating Margin % -22.6%20.3%20.0%13.3%
Net Margin % -15.5%12.5%12.7%6.2%
ROE % -20.1%17.0%18.0%10.7%
ROCE % -18.5%14.8%12.4%8.0%

Shareholding Pattern

Insiders
43.80%
Institutions
39.79%
Public Float
70.80%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for KIMS

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks